tyloxapol has been researched along with Lung Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dennis, JJ; Finlay, WH; Lynch, KH; Matinkhoo, S; Vehring, R | 1 |
| DIAZ NIELSEN, JR | 1 |
| Ghio, AJ; Sachs, S; Young, SL | 1 |
3 other study(ies) available for tyloxapol and Lung Diseases
| Article | Year |
|---|---|
Spray-dried respirable powders containing bacteriophages for the treatment of pulmonary infections.
Topics: Administration, Inhalation; Aerosols; Bacteriophages; Caseins; Desiccation; Drug Compounding; Dry Powder Inhalers; Excipients; Humans; Lung; Lung Diseases; Myoviridae; Particle Size; Polyethylene Glycols; Powders; Pseudomonas aeruginosa; Respiratory Tract Infections; Surface-Active Agents; Trehalose | 2011 |
[Therapy of bronchial obstructions of coagulated secretions with the new technic of continuous nebulization with Alevaire].
Topics: Aerosols; Bronchi; Bronchial Diseases; Disease; Lung Diseases; Polyethylene Glycols; Surface-Active Agents | 1954 |
Tyloxapol confers durable protection against hyperoxic lung injury in the rat.
Topics: Animals; Catalase; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fatty Alcohols; Glutathione Peroxidase; Half-Life; Hyperoxia; Intubation, Intratracheal; Lung; Lung Diseases; Male; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms; Superoxide Dismutase; Surface-Active Agents | 1999 |